Correlation between Thrombus Perviousness and Distal Embolization during Mechanical Thrombectomy in Acute Stroke.

acute ischemic stroke clot histology computed tomography distal embolization multiphase computed tomography angiography rt-PA thrombectomy thrombus perviousness

Journal

Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402

Informations de publication

Date de publication:
25 Jan 2023
Historique:
received: 10 11 2022
revised: 07 01 2023
accepted: 21 01 2023
entrez: 11 2 2023
pubmed: 12 2 2023
medline: 12 2 2023
Statut: epublish

Résumé

Thrombus permeability has been related to clot composition and treatment outcomes in stroke patients undergoing reperfusion therapies. The aim of this study was to evaluate whether thrombus perviousness, evaluated by multiphase computed tomography angiography (mCTA), is associated with distal embolization risk. We interrogated our dataset of acute ischemic stroke (AIS) patients involving the M1 segment of the middle cerebral artery (MCA) who had undergone mechanical thrombectomy, and we calculated thrombus average attenuation measurement (dHU) on non-contrast CT (NCCT) and clot perviousness on mCTA. dHU was calculated as the difference between the thrombus HU average value (tHU) and the HU average value on the contralateral side (cHU), while perviousness was calculated as the difference in mean clot density on mCTA and NCCT both in arterial (Perviousness pre-post-1) and delayed (Perviousness pre-post 2) phases. A total of 100 patients (53 females (53%), mean age 72.74 [± 2.31]) with M1 occlusion were available for analysis. Perviousness, calculated between baseline and arterial phase of mCTA (Perviousness pre-post1), was lower in patients with distal embolization ( Our study showed an association between reduced perviousness and distal embolization, suggesting that perviousness evaluation may be a useful neuroimaging biomarker in predicting distal embolization risk during mechanical thrombectomy.

Identifiants

pubmed: 36766536
pii: diagnostics13030431
doi: 10.3390/diagnostics13030431
pmc: PMC9914329
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Interv Neuroradiol. 2019 Jun;25(3):285-290
pubmed: 30714501
J Neurointerv Surg. 2017 Oct;9(10):937-939
pubmed: 27634955
Clin Neurol Neurosurg. 2020 Nov;198:106207
pubmed: 32950754
Clin Neuroradiol. 2021 Sep;31(3):773-781
pubmed: 32990766
Stroke. 2021 Mar;52(3):1131-1142
pubmed: 33563020
J Neurointerv Surg. 2023 Feb;15(2):146-152
pubmed: 35110399
Stroke. 2009 Dec;40(12):3777-83
pubmed: 19875740
J Neurol Sci. 2022 Jan 15;432:120087
pubmed: 34933250
PLoS One. 2014 Feb 11;9(2):e88882
pubmed: 24523944
Stroke. 2018 Nov;49(11):2674-2682
pubmed: 30355200
AJNR Am J Neuroradiol. 2021 Jan;42(1):57-64
pubmed: 33243895
Blood. 2014 Sep 11;124(11):1808-15
pubmed: 24951424
Circulation. 2019 Mar 5;139(10):e56-e528
pubmed: 30700139
Clin Neuroradiol. 2016 Jun;26(2):189-97
pubmed: 25261075
J Neurol Sci. 2021 Nov 15;430:119989
pubmed: 34547614
Stroke. 2016 Mar;47(3):732-41
pubmed: 26846859
Brain Sci. 2020 Nov 20;10(11):
pubmed: 33233665
Brain Sci. 2020 Nov 26;10(12):
pubmed: 33256264
Stroke. 2016 Aug;47(8):2058-65
pubmed: 27338928
Radiology. 2003 Jul;228(1):126-30
pubmed: 12728185
J Stroke Cerebrovasc Dis. 2020 Feb;29(2):104541
pubmed: 31810719
Arch Intern Med. 2003 Nov 10;163(20):2534-5; author reply 2535
pubmed: 14609795
Int J Stroke. 2021 Jan;16(1):20-28
pubmed: 32380902
J Neurointerv Surg. 2020 Jan;12(1):38-42
pubmed: 31239329
Stroke. 2019 Dec;50(12):e344-e418
pubmed: 31662037
Neurology. 2019 Oct 29;93(18):e1686-e1698
pubmed: 31541014

Auteurs

Fabio Pilato (F)

Department of Medicine and Surgery, Unit of Neurology, Neurophysiology, Neurobiology and Psichiatry, Università Campus Bio-Medico di Roma, Via Alvaro del Portillo, 00128 Roma, Italy.
Operative Research Unit of Neurology, Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo, 00128 Roma, Italy.

Iacopo Valente (I)

UOC Radiologia e Neuroradiologia, Polo Diagnostica Per Immagini, Radioterapia, Oncologia ed Ematologia, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma-Area Diagnostica Per Immagini, 00168 Rome, Italy.

Andrea M Alexandre (AM)

UOC Radiologia e Neuroradiologia, Polo Diagnostica Per Immagini, Radioterapia, Oncologia ed Ematologia, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma-Area Diagnostica Per Immagini, 00168 Rome, Italy.

Rosalinda Calandrelli (R)

UOC Radiologia e Neuroradiologia, Polo Diagnostica Per Immagini, Radioterapia, Oncologia ed Ematologia, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma-Area Diagnostica Per Immagini, 00168 Rome, Italy.

Luca Scarcia (L)

UOC Radiologia e Neuroradiologia, Polo Diagnostica Per Immagini, Radioterapia, Oncologia ed Ematologia, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma-Area Diagnostica Per Immagini, 00168 Rome, Italy.

Francesco D'Argento (F)

UOC Radiologia e Neuroradiologia, Polo Diagnostica Per Immagini, Radioterapia, Oncologia ed Ematologia, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma-Area Diagnostica Per Immagini, 00168 Rome, Italy.

Emilio Lozupone (E)

Department of Neuroradiology, Vito Fazzi Hospital, 73100 Lecce, Italy.

Vincenzo Arena (V)

Istituto di Anatomia Patologica, Dipartimento Scienze della Salute della Donna, del Bambino e di Sanità Pubblica-Area Anatomia Patologica-Fondazione Policlinico Universitario Agostino Gemelli IRCCS, 00168 Roma, Italy.

Alessandro Pedicelli (A)

UOC Radiologia e Neuroradiologia, Polo Diagnostica Per Immagini, Radioterapia, Oncologia ed Ematologia, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma-Area Diagnostica Per Immagini, 00168 Rome, Italy.

Classifications MeSH